Buspirone: An anxioselective alternative for the management of anxiety disorders (Q39561166)

13 September 2017

title

Buspirone: an anxioselective alternative for the management of anxiety disorders (English)

1 reference

13 September 2017

Buspirone: An anxioselective alternative for the management of anxiety disorders (English)

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90042-8

8 October 2023

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90042-8

8 October 2023

author name string

Temple DL Jr

6

1 reference

13 September 2017

L. A. Riblet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6364236

8 October 2023

A. S. Eison

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6364236

8 October 2023

M. S. Eison

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6364236

8 October 2023

R. E. Newton

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6364236

8 October 2023

D. P. Taylor

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6364236

8 October 2023

D. L. Temple

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6364236

8 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6364236

8 October 2023

publication date

1 January 1983

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:0278584683900428?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90042-8

https://api.elsevier.com/content/article/PII:0278584683900428?httpAccept=text/plain

8 October 2023

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90042-8

Progress in Neuro-Psychopharmacology & Biological Psychiatry

8 October 2023

published in

1 reference

13 September 2017

volume

7

1 reference

13 September 2017

issue

4-6

1 reference

13 September 2017

page(s)

663-668

1 reference

Intravenous buspirone self-administration in rhesus monkeys

13 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90042-8

Dopaminergic effects of buspirone, a novel anxiolytic agent

8 October 2023

2

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90042-8

Assessment of the abuse liability of buspirone in recreational sedative users

8 October 2023

3

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90042-8

A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder

8 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90042-8

The comparative efficacy of buspirone and diazepam in the treatment of anxiety

8 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90042-8

Comparison of buspirone in two separate studies

8 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90042-8

Discriminative stimulus properties of buspirone compared to central nervous system depressants in rats.

8 October 2023

10

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90042-8

Neurochemical effects of buspirone, a novel psychotropic drug, on the central cholinergic system

8 October 2023

12

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90042-8

Selective effects of buspirone and molindone on dopamine metabolism and function in the striatum and frontal cortex of the rat

8 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90042-8

Dopamine receptor antagonism by the novel antianxiety drug, buspirone

8 October 2023

15

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90042-8

The side effect profile of buspirone in comparison to active controls and placebo

8 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90042-8

Pharmacology and neurochemistry of buspirone

8 October 2023

17

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90042-8

Buspirone and diazepam in anxiety: a controlled study

8 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90042-8

Buspirone, a non-benzodiazepine anxiolytic, increases locus coeruleus noradrenergic neuronal activity

8 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90042-8

MJ 9022: correlation between neuroleptic potential and stereotypy

8 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90042-8

Dopamine and antianxiety activity

8 October 2023

22

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90042-8

Buspirone: multicenter efficacy study

8 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90042-8

8 October 2023

Identifiers

1 reference

release_ew2ddnhdpnhcvax5as357mtzam

13 September 2017

Fatcat ID

0 references

1 reference